Revenue
3.05 billion USD
2026 Q3 · USD
Exact inputs and evidence
- Revenue: 3048700000 USD Source
Fundies. English
INTUITIVE SURGICAL, INC.
EDGARAnnual consolidated revenue for 2025: about USD 10.06B, using the latest reported figures. The previous period, 2024, was about USD 8.352B.
Latest quarter
Operating margin
19.44%
2026 Q3 · %
Operating cash flow
1.22 billion USD
2026 Q3 · USD
- Cash and cash equivalents
- 2.98 billion USD Source
Exact value
2978100000 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 347 million shares Source
Exact value
346600000 shares
Reported share-count change
-2.34% · -8.3 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
11.6 billion USD
2025-10-01 – 2026-09-30
Exact inputs and evidence
Net income
2.96 billion USD
2025-10-01 – 2026-09-30
Exact inputs and evidence
Operating cash flow
4.09 billion USD
2025-10-01 – 2026-09-30
Exact inputs and evidence
- Operating cash flow: 3030500000 USD · 2025-01-01 – 2025-12-31 Source
- Operating cash flow: 2138000000 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: 911900000 USD · 2026-01-01 – 2026-03-31 Source
- Operating cash flow: 1972900000 USD · 2026-01-01 – 2026-06-30 Source
- Operating cash flow: 911900000 USD · 2026-01-01 – 2026-03-31 Source
- Operating cash flow: 3197000000 USD · 2026-01-01 – 2026-09-30 Source
- Operating cash flow: 1972900000 USD · 2026-01-01 – 2026-06-30 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-23.
Financial data available through: 2025-12-31.
Coverage by financial measure
- Revenue: 11 of 11 periods available· newest 2025-12-31
- Operating income: 11 of 11 periods available· newest 2025-12-31
- Net income: 11 of 11 periods available· newest 2025-12-31
- Operating cash flow: 11 of 11 periods available· newest 2025-12-31
- capital expenditure: No compatible figures in this window
- Total assets: 11 of 11 periods available· newest 2025-12-31
- Total liabilities: 11 of 11 periods available· newest 2025-12-31
- Current assets: 11 of 11 periods available· newest 2025-12-31
- Current liabilities: 11 of 11 periods available· newest 2025-12-31
- Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
- long term debt: No compatible figures in this window
- Shares outstanding: 11 of 11 periods available· newest 2025-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
+20.5%Prior period
USD 8.35 billion
–
Current period
USD 10.06 billion
–
Exact inputs and evidence
10064700000 − 8352100000 = 1712600000 USD
8352100000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source10064700000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
+23%Prior period
USD 2.32 billion
–
Current period
USD 2.86 billion
–
Exact inputs and evidence
2856000000 − 2322600000 = 533400000 USD
2322600000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source2856000000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+25.5%Prior period
USD 2.42 billion
–
Current period
USD 3.03 billion
–
Exact inputs and evidence
3030500000 − 2415000000 = 615500000 USD
2415000000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source3030500000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2025 2025-01-01 – 2025-12-31
- Revenue USD 10.06 billion 100% of revenue
- Cost of revenue USD 3.42 billion 34% of revenue
- Operating expenses USD 3.7 billion 37% of revenue
- Operating income USD 2.95 billion 29% of revenue
- Tax, interest and other Derived USD 89.5 million 0.9% of revenue
- Net income USD 2.86 billion 28% of revenue
Cash
- Operating cash flow USD 3.03 billion 30% of revenue
- Capital expenditure Unavailable An input is unavailable.
- Free cash flow Derived Unavailable An input is unavailable.
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2016 27%65%
- 2017 21%12%66%
- 2018 30%68%
- 2019 Net income was higher than operating income, so the split is not drawn.
- 2020 Net income was higher than operating income, so the split is not drawn.
- 2021 30%68%
- 2022 21%75%
- 2023 Net income was higher than operating income, so the split is not drawn.
- 2024 28%72%
- 2025 28%71%
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2016 2016-01-01 – 2016-12-31 | 2706500000 | 1756800000 Derived | 949700000 | 211400000 Derived | 738300000 | Unavailable | Source
|
| 2017 2017-01-01 – 2017-12-31 | 3138200000 | 2075300000 Derived | 1062900000 | 392000000 Derived | 670900000 | Unavailable | Source
|
| 2018 2018-01-01 – 2018-12-31 | 3724200000 | 2524800000 Derived | 1199400000 | 71500000 Derived | 1127900000 | Unavailable | Source
|
| 2019 2019-01-01 – 2019-12-31 | 4478500000 | 3104000000 Derived | 1374500000 | -4800000 Derived | 1379300000 | Unavailable | Source
|
| 2020 2020-01-01 – 2020-12-31 | 4358400000 | 3308600000 Derived | 1049800000 | -10800000 Derived | 1060600000 | Unavailable | Source
|
| 2021 2021-01-01 – 2021-12-31 | 5710100000 | 3889100000 Derived | 1821000000 | 116400000 Derived | 1704600000 | Unavailable | Source
|
| 2022 2022-01-01 – 2022-12-31 | 6222200000 | 4645100000 Derived | 1577100000 | 254800000 Derived | 1322300000 | Unavailable | Source
|
| 2023 2023-01-01 – 2023-12-31 | 7124100000 | 5357300000 Derived | 1766800000 | -31200000 Derived | 1798000000 | Unavailable | Source
|
| 2024 2024-01-01 – 2024-12-31 | 8352100000 | 6003200000 Derived | 2348900000 | 26300000 Derived | 2322600000 | Unavailable | Source
|
| 2025 2025-01-01 – 2025-12-31 | 10064700000 | 7119200000 Derived | 2945500000 | 89500000 Derived | 2856000000 | Unavailable | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 10.1B 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Revenue | 2706500000 |
|
| 2017 | Revenue | 3138200000 |
|
| 2018 | Revenue | 3724200000 |
|
| 2019 | Revenue | 4478500000 |
|
| 2020 | Revenue | 4358400000 |
|
| 2021 | Revenue | 5710100000 |
|
| 2022 | Revenue | 6222200000 |
|
| 2023 | Revenue | 7124100000 |
|
| 2024 | Revenue | 8352100000 |
|
| 2025 | Revenue | 10064700000 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
20.5% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Year over year | 13.5% |
|
| 2017 | Year over year | 16% |
|
| 2018 | Year over year | 18.7% |
|
| 2019 | Year over year | 20.3% |
|
| 2020 | Year over year | -2.7% |
|
| 2021 | Year over year | 31% |
|
| 2022 | Year over year | 9% |
|
| 2023 | Year over year | 14.5% |
|
| 2024 | Year over year | 17.2% |
|
| 2025 | Year over year | 20.5% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin 29.3% 2025
Net margin 28.4% 2025
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Operating margin | 35.1% |
|
| 2017 | Operating margin | 33.9% |
|
| 2018 | Operating margin | 32.2% |
|
| 2019 | Operating margin | 30.7% |
|
| 2020 | Operating margin | 24.1% |
|
| 2021 | Operating margin | 31.9% |
|
| 2022 | Operating margin | 25.3% |
|
| 2023 | Operating margin | 24.8% |
|
| 2024 | Operating margin | 28.1% |
|
| 2025 | Operating margin | 29.3% |
|
| 2016 | Net margin | 27.3% |
|
| 2017 | Net margin | 21.4% |
|
| 2018 | Net margin | 30.3% |
|
| 2019 | Net margin | 30.8% |
|
| 2020 | Net margin | 24.3% |
|
| 2021 | Net margin | 29.9% |
|
| 2022 | Net margin | 21.3% |
|
| 2023 | Net margin | 25.2% |
|
| 2024 | Net margin | 27.8% |
|
| 2025 | Net margin | 28.4% |
|
| 2016 | Free cash flow margin | Not reported |
|
| 2017 | Free cash flow margin | Not reported |
|
| 2018 | Free cash flow margin | Not reported |
|
| 2019 | Free cash flow margin | Not reported |
|
| 2020 | Free cash flow margin | Not reported |
|
| 2021 | Free cash flow margin | Not reported |
|
| 2022 | Free cash flow margin | Not reported |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD 3B 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Operating cash flow | 1087000000 |
|
| 2017 | Operating cash flow | 1143900000 |
|
| 2018 | Operating cash flow | 1169600000 |
|
| 2019 | Operating cash flow | 1598200000 |
|
| 2020 | Operating cash flow | 1484800000 |
|
| 2021 | Operating cash flow | 2089400000 |
|
| 2022 | Operating cash flow | 1490800000 |
|
| 2023 | Operating cash flow | 1813800000 |
|
| 2024 | Operating cash flow | 2415000000 |
|
| 2025 | Operating cash flow | 3030500000 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Free cash flow | Unavailable |
|
| 2017 | Free cash flow | Unavailable |
|
| 2018 | Free cash flow | Unavailable |
|
| 2019 | Free cash flow | Unavailable |
|
| 2020 | Free cash flow | Unavailable |
|
| 2021 | Free cash flow | Unavailable |
|
| 2022 | Free cash flow | Unavailable |
|
| 2023 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | Unavailable |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
12.3% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Liabilities / assets | 10.9% |
|
| 2017 | Liabilities / assets | 17.2% |
|
| 2018 | Liabilities / assets | 14.8% |
|
| 2019 | Liabilities / assets | 14.9% |
|
| 2020 | Liabilities / assets | 12.6% |
|
| 2021 | Liabilities / assets | 11.8% |
|
| 2022 | Liabilities / assets | 14.3% |
|
| 2023 | Liabilities / assets | 13.2% |
|
| 2024 | Liabilities / assets | 11.8% |
|
| 2025 | Liabilities / assets | 12.3% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
4.87× 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Current assets / current liabilities | 5.45× |
|
| 2017 | Current assets / current liabilities | 4.24× |
|
| 2018 | Current assets / current liabilities | 5.28× |
|
| 2019 | Current assets / current liabilities | 4.53× |
|
| 2020 | Current assets / current liabilities | 6.86× |
|
| 2021 | Current assets / current liabilities | 5.08× |
|
| 2022 | Current assets / current liabilities | 4.4× |
|
| 2023 | Current assets / current liabilities | 4.76× |
|
| 2024 | Current assets / current liabilities | 4.07× |
|
| 2025 | Current assets / current liabilities | 4.87× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2016 2016-01-01 – 2016-12-31 | USD 738.3 million Exact valueExact value: 738300000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.09 billion Exact valueExact value: 1087000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2017 2017-01-01 – 2017-12-31 | USD 670.9 million Exact valueExact value: 670900000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.14 billion Exact valueExact value: 1143900000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2018 2018-01-01 – 2018-12-31 | USD 1.13 billion Exact valueExact value: 1127900000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.17 billion Exact valueExact value: 1169600000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2019-01-01 – 2019-12-31 | USD 1.38 billion Exact valueExact value: 1379300000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.6 billion Exact valueExact value: 1598200000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2020-01-01 – 2020-12-31 | USD 1.06 billion Exact valueExact value: 1060600000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.48 billion Exact valueExact value: 1484800000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2021-01-01 – 2021-12-31 | USD 1.7 billion Exact valueExact value: 1704600000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2.09 billion Exact valueExact value: 2089400000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2022-01-01 – 2022-12-31 | USD 1.32 billion Exact valueExact value: 1322300000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.49 billion Exact valueExact value: 1490800000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2023-01-01 – 2023-12-31 | USD 1.8 billion Exact valueExact value: 1798000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.81 billion Exact valueExact value: 1813800000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | USD 2.32 billion Exact valueExact value: 2322600000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2.42 billion Exact valueExact value: 2415000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | USD 2.86 billion Exact valueExact value: 2856000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 3.03 billion Exact valueExact value: 3030500000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
373 filings · 6,307 latest values · 6,307 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001035267, 1035267, ISRG, edgar:1035267, isrg
Also known as INTUITIVE SURGICAL INC, INTUITIVE SURGICAL, INC., Intuitive Surgical, Inc.